GMO Research & AI, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
276.00
248.00
428.00
458.00
385.00
240.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
590.00
-42.00
114.00
-233.00
128.00
118.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
990.00
237.00
475.00
131.00
482.00
363.00
Cash Flow from Investing Activities
-379.00
-221.00
-131.00
-111.00
-50.00
-95.00
Cash Flow from Financing Activities
455.00
-195.00
-187.00
-145.00
-96.00
-82.00
Net Cash Inflow / Outflow
1,083.00
-146.00
167.00
-97.00
351.00
185.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
16.00
33.00
11.00
27.00
16.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of GMO Research & AI, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
276.641
2597.715
-2,321.00
-89.35%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
590.793
363.961
227.00
62.32%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
990.783
2704.769
-1,714.00
-63.37%
Cash Flow from Investing Activities
-379.843
-53.029
-326.00
-616.29%
Cash Flow from Financing Activities
455.827
-799.591
1,254.00
157.01%
Net Cash Inflow / Outflow
1083.688
1852.734
-769.00
-41.51%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
16.921
0.585
16.00
2792.48%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 317.16% vs -50.05% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
990.78
237.50
317.16%






